141 related articles for article (PubMed ID: 2828680)
1. Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.
van Strijp JA; van Kessel KP; Miltenburg LA; Fluit AC; Verhoef J
J Virol; 1988 Mar; 62(3):847-50. PubMed ID: 2828680
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade.
Fries LF; Friedman HM; Cohen GH; Eisenberg RJ; Hammer CH; Frank MM
J Immunol; 1986 Sep; 137(5):1636-41. PubMed ID: 3018078
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.
Posavad CM; Rosenthal KL
J Virol; 1992 Nov; 66(11):6264-72. PubMed ID: 1328666
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
5. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts.
Fitzgerald-Bocarsly P; Howell DM; Pettera L; Tehrani S; Lopez C
J Virol; 1991 Jun; 65(6):3151-60. PubMed ID: 1709697
[TBL] [Abstract][Full Text] [Related]
6. Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
Van Kessel KP; Van Kats-Renaud HJ; Van Strijp JA; Visser MR; Verhoef J
J Immunol Methods; 1986 Apr; 88(1):101-7. PubMed ID: 3007623
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.
Hook LM; Lubinski JM; Jiang M; Pangburn MK; Friedman HM
J Virol; 2006 Apr; 80(8):4038-46. PubMed ID: 16571820
[TBL] [Abstract][Full Text] [Related]
8. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
Sissons JG; Oldstone MB; Schreiber RD
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):559-62. PubMed ID: 6928644
[TBL] [Abstract][Full Text] [Related]
10. Binding and internalization of herpes simplex virus-antibody complexes by polymorphonuclear leukocytes.
Smith JW; Jachimowicz JR; Bingham EL
J Med Virol; 1986 Oct; 20(2):151-63. PubMed ID: 3021898
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
Nemerow GR; Jensen FC; Cooper NR
J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
[TBL] [Abstract][Full Text] [Related]
12. Lysis of herpes simplex virus-infected cells by lymphokine-activated killer cells.
Chu CT; Lee P; Lin BJ; Sun MJ; Hsieh KH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):108-18. PubMed ID: 1657543
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis.
Huemer HP; Wechselberger C; Bennett AM; Falke D; Harrington L
J Gen Virol; 2003 May; 84(Pt 5):1091-1100. PubMed ID: 12692273
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.
Friedman HM; Wang L; Pangburn MK; Lambris JD; Lubinski J
J Immunol; 2000 Oct; 165(8):4528-36. PubMed ID: 11035093
[TBL] [Abstract][Full Text] [Related]
15. Activation of complement on the surface of cells infected by human immunodeficiency virus.
Spear GT; Landay AL; Sullivan BL; Dittel B; Lint TF
J Immunol; 1990 Feb; 144(4):1490-6. PubMed ID: 1968081
[TBL] [Abstract][Full Text] [Related]
16. Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity.
Yefenof E; Asjö B; Klein E
Int Immunol; 1991 Apr; 3(4):395-401. PubMed ID: 1878340
[TBL] [Abstract][Full Text] [Related]
17. Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells.
Capobianchi MR; Malavasi F; Di Marco P; Dianzani F
Arch Virol; 1988; 103(3-4):219-29. PubMed ID: 2850784
[TBL] [Abstract][Full Text] [Related]
18. HIV and HIV-infected cells differentially activate the human complement system independent of antibody.
Sölder BM; Schulz TF; Hengster P; Löwer J; Larcher C; Bitterlich G; Kurth R; Wachter H; Dierich MP
Immunol Lett; 1989 Aug; 22(2):135-45. PubMed ID: 2789186
[TBL] [Abstract][Full Text] [Related]
19. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
20. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
